Point72 (DIFC)’s OptimizeRx OPRX Stock Holding History

Point72 (DIFC)’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35	Closed	-$425	–	1791
2024 Q1	$425	Buy	+35	New	+$508	﹤0.01%	1415

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Point72 (DIFC)'s OPRX Position: Q2 2024 in Review

Point72 (DIFC) sold out of OptimizeRx (OPRX) in Q2 2024, closing a stake of 35 shares — an estimated $425 sold.

Point72 (DIFC) first reported a position in OPRX in Q1 2024 and held it in 1 quarter. The position peaked at $425 in Q1 2024. 92 funds tracked by Wall St. Rank hold OPRX as of Q2 2024.

Point72 (DIFC) reported no remaining OptimizeRx position as of Q2 2024 after selling out during the quarter.
Point72 (DIFC) sold 35 OptimizeRx shares in Q2 2024, an estimated $425.
Point72 (DIFC) first reported a position in OptimizeRx in Q1 2024 and held it in 1 quarter.
Point72 (DIFC)'s OptimizeRx position peaked at $425 in Q1 2024.
92 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2024.

Based on Point72 (DIFC)'s 13F filing for Q2 2024, filed 14 Aug 2024.